2018-2023 Global Cervical Cancer Diagnostic Testing Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cervical Cancer Diagnostic Testing market for 2018-2023.
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
North America accounted for the largest share of the global market, followed by Europe.
Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region.
Over the next five years, LPI(LP Information) projects that Cervical Cancer Diagnostic Testing will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Cervical Cancer Diagnostic Testing market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Pap Testing
HPV Testing
Colposcopy
Cervical Biopsies
Segmentation by application:
Hospitals
Cancer Palliative care clinics
Diagnostic centers
Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Profectus Biosciences
Virometix
Hologic
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cervical Cancer Diagnostic Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Cervical Cancer Diagnostic Testing market by identifying its various subsegments.
Focuses on the key global Cervical Cancer Diagnostic Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cervical Cancer Diagnostic Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cervical Cancer Diagnostic Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Cervical Cancer Diagnostic Testing Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cervical Cancer Diagnostic Testing Consumption 2013-2023
2.1.2 Cervical Cancer Diagnostic Testing Consumption CAGR by Region
2.2 Cervical Cancer Diagnostic Testing Segment by Type
2.2.1 Pap Testing
2.2.2 HPV Testing
2.2.3 Colposcopy
2.2.4 Cervical Biopsies
2.3 Cervical Cancer Diagnostic Testing Consumption by Type
2.3.1 Global Cervical Cancer Diagnostic Testing Consumption Market Share by Type (2013-2018)
2.3.2 Global Cervical Cancer Diagnostic Testing Revenue and Market Share by Type (2013-2018)
2.3.3 Global Cervical Cancer Diagnostic Testing Sale Price by Type (2013-2018)
2.4 Cervical Cancer Diagnostic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Cancer Palliative care clinics
2.4.3 Diagnostic centers
2.4.4 Pharmacies
2.5 Cervical Cancer Diagnostic Testing Consumption by Application
2.5.1 Global Cervical Cancer Diagnostic Testing Consumption Market Share by Application (2013-2018)
2.5.2 Global Cervical Cancer Diagnostic Testing Value and Market Share by Application (2013-2018)
2.5.3 Global Cervical Cancer Diagnostic Testing Sale Price by Application (2013-2018)
3 Global Cervical Cancer Diagnostic Testing by Players
3.1 Global Cervical Cancer Diagnostic Testing Sales Market Share by Players
3.1.1 Global Cervical Cancer Diagnostic Testing Sales by Players (2016-2018)
3.1.2 Global Cervical Cancer Diagnostic Testing Sales Market Share by Players (2016-2018)
3.2 Global Cervical Cancer Diagnostic Testing Revenue Market Share by Players
3.2.1 Global Cervical Cancer Diagnostic Testing Revenue by Players (2016-2018)
3.2.2 Global Cervical Cancer Diagnostic Testing Revenue Market Share by Players (2016-2018)
3.3 Global Cervical Cancer Diagnostic Testing Sale Price by Players
3.4 Global Cervical Cancer Diagnostic Testing Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Cervical Cancer Diagnostic Testing Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Cervical Cancer Diagnostic Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cervical Cancer Diagnostic Testing by Regions
4.1 Cervical Cancer Diagnostic Testing by Regions
4.1.1 Global Cervical Cancer Diagnostic Testing Consumption by Regions
4.1.2 Global Cervical Cancer Diagnostic Testing Value by Regions
4.2 Americas Cervical Cancer Diagnostic Testing Consumption Growth
4.3 APAC Cervical Cancer Diagnostic Testing Consumption Growth
4.4 Europe Cervical Cancer Diagnostic Testing Consumption Growth
4.5 Middle East & Africa Cervical Cancer Diagnostic Testing Consumption Growth
5 Americas
5.1 Americas Cervical Cancer Diagnostic Testing Consumption by Countries
5.1.1 Americas Cervical Cancer Diagnostic Testing Consumption by Countries (2013-2018)
5.1.2 Americas Cervical Cancer Diagnostic Testing Value by Countries (2013-2018)
5.2 Americas Cervical Cancer Diagnostic Testing Consumption by Type
5.3 Americas Cervical Cancer Diagnostic Testing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cervical Cancer Diagnostic Testing Consumption by Countries
6.1.1 APAC Cervical Cancer Diagnostic Testing Consumption by Countries (2013-2018)
6.1.2 APAC Cervical Cancer Diagnostic Testing Value by Countries (2013-2018)
6.2 APAC Cervical Cancer Diagnostic Testing Consumption by Type
6.3 APAC Cervical Cancer Diagnostic Testing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Cervical Cancer Diagnostic Testing by Countries
7.1.1 Europe Cervical Cancer Diagnostic Testing Consumption by Countries (2013-2018)
7.1.2 Europe Cervical Cancer Diagnostic Testing Value by Countries (2013-2018)
7.2 Europe Cervical Cancer Diagnostic Testing Consumption by Type
7.3 Europe Cervical Cancer Diagnostic Testing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cervical Cancer Diagnostic Testing by Countries
8.1.1 Middle East & Africa Cervical Cancer Diagnostic Testing Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Cervical Cancer Diagnostic Testing Value by Countries (2013-2018)
8.2 Middle East & Africa Cervical Cancer Diagnostic Testing Consumption by Type
8.3 Middle East & Africa Cervical Cancer Diagnostic Testing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Cervical Cancer Diagnostic Testing Distributors
10.3 Cervical Cancer Diagnostic Testing Customer
11 Global Cervical Cancer Diagnostic Testing Market Forecast
11.1 Global Cervical Cancer Diagnostic Testing Consumption Forecast (2018-2023)
11.2 Global Cervical Cancer Diagnostic Testing Forecast by Regions
11.2.1 Global Cervical Cancer Diagnostic Testing Forecast by Regions (2018-2023)
11.2.2 Global Cervical Cancer Diagnostic Testing Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cervical Cancer Diagnostic Testing Forecast by Type
11.8 Global Cervical Cancer Diagnostic Testing Forecast by Application
12 Key Players Analysis
12.1 F. Hoffmann-La Roche
12.1.1 Company Details
12.1.2 Cervical Cancer Diagnostic Testing Product Offered
12.1.3 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 F. Hoffmann-La Roche News
12.2 GlaxoSmithKline
12.2.1 Company Details
12.2.2 Cervical Cancer Diagnostic Testing Product Offered
12.2.3 GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GlaxoSmithKline News
12.3 Merck
12.3.1 Company Details
12.3.2 Cervical Cancer Diagnostic Testing Product Offered
12.3.3 Merck Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 Advaxis Immunotherapies
12.4.1 Company Details
12.4.2 Cervical Cancer Diagnostic Testing Product Offered
12.4.3 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Advaxis Immunotherapies News
12.5 Bionor Pharma
12.5.1 Company Details
12.5.2 Cervical Cancer Diagnostic Testing Product Offered
12.5.3 Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Bionor Pharma News
12.6 Dendreon Corporation
12.6.1 Company Details
12.6.2 Cervical Cancer Diagnostic Testing Product Offered
12.6.3 Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Dendreon Corporation News
12.7 Inovio Pharmaceuticals
12.7.1 Company Details
12.7.2 Cervical Cancer Diagnostic Testing Product Offered
12.7.3 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Inovio Pharmaceuticals News
12.8 ISA Pharmaceuticals
12.8.1 Company Details
12.8.2 Cervical Cancer Diagnostic Testing Product Offered
12.8.3 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 ISA Pharmaceuticals News
12.9 Otsuka Pharmaceuticals
12.9.1 Company Details
12.9.2 Cervical Cancer Diagnostic Testing Product Offered
12.9.3 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Otsuka Pharmaceuticals News
12.10 Profectus Biosciences
12.10.1 Company Details
12.10.2 Cervical Cancer Diagnostic Testing Product Offered
12.10.3 Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Profectus Biosciences News
12.11 Virometix
12.12 Hologic
13 Research Findings and Conclusion
